Home
About
Leadership
Medical Advisory Board (AC5)
Scientific & Clinical Advisors
Corporate Mission
Products
Ordering Information
Intellectual Property
AC5 Advanced Wound System
Technology
Platform
Preclinical Data
Clinical Data
Pipeline
Pipeline Opportunity
Investors
Investor Relations
IR Overview
News
Press Releases
IR Calendar
Presentations
Interviews
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Corporate Governance
Governance Documents
Contact
Home
Investors
News
Press Releases
Investors
Overview
News
Press Releases
IR Calendar
Presentations
Interviews
Stock Data
SEC Filings
Corporate Governance
Press Releases
All News
By Year:
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
06/6/16
Arch Therapeutics Completes Patient Enrollment in Clinical Study of AC5
05/27/16
Arch Therapeutics Announces May 26, 2016 $3.4 Million Private Placement
05/16/16
Arch Therapeutics Announces Issuance of Composition of Matter Patent Covering Self-Assembling Peptidomimetics
05/10/16
Arch Therapeutics Receives Notice of Allowance for Composition of Matter and Method of Use Patent Covering Solid Forms of Self-Assembling Peptides
04/26/16
Arch Therapeutics to Present at PIONEERS 2016 by Joseph Gunnar & Co. Thursday, May 5, 2016
04/25/16
Arch Therapeutics Receives Notice of Allowance for Patent Covering Systemic Applications for Self-Assembling Peptides
04/11/16
Arch Therapeutics Announces Notice of Allowance for Method of Use Patent Covering Uses of Self-Assembling Peptides
04/5/16
Arch Therapeutics Announces Notice of Allowance for Composition-of-Matter Patent Covering Self-Assembling Peptides
03/22/16
Arch Therapeutics Obtains Favorable Safety Data for AC5 Surgical Hemostatic Device(TM) in Skin Irritation Testing in Humans
03/14/16
Arch Therapeutics Reports Favorable Results for AC5 Surgical Hemostatic Device in Biocompatibility Testing Required for CE Mark
<< Previous
1...
5
6
7
8
9
10
11
12
13
14
Next >>
Show All